Yakang Biotech announced that Nanjing Laoyan, Zhoushan Conglomerate, Zhejiang Xiyan, Zhejiang Guyan, and Zhejiang Xingyan plan to transfer a total of 10.6518 million shares through an inquiry, accounting for 2.60% of the company's total share capital, due to its own capital requirements. This inquiry and transfer will not be carried out through centralized bidding transactions or bulk transactions. The transferee is an institutional investor, and shares cannot be transferred within 6 months after the transfer of shares.

Zhitongcaijing · 1d ago
Yakang Biotech announced that Nanjing Laoyan, Zhoushan Conglomerate, Zhejiang Xiyan, Zhejiang Guyan, and Zhejiang Xingyan plan to transfer a total of 10.6518 million shares through an inquiry, accounting for 2.60% of the company's total share capital, due to its own capital requirements. This inquiry and transfer will not be carried out through centralized bidding transactions or bulk transactions. The transferee is an institutional investor, and shares cannot be transferred within 6 months after the transfer of shares.